Financhill
Back

ImmunityBio 10K Form

Buy
72

IBRX
ImmunityBio

Last Price:
7.64
Seasonality Move:
15.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IBRX News And Ratings

See the #1 stock for the next 7 days that we like better than IBRX

IBRX Financial Statistics

Sales & Book Value

Annual Sales: $622K
Cash Flow: $-108.24M
Price / Cash Flow: 0
Annual Sales: $-1.02
Price / Book: 0

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-600.96M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -152.36%

ImmunityBio Earnings Forecast

Key ImmunityBio Financial Ratios

  • The Research & Development expenses have been 37,357.88% of Revenue.
  • The Interest Expense is -22.15% of Operating Income.
  • The Net Earning history of IBRX is -93,761.41% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 0 years.

ImmunityBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IBRX
Website: immunitybio.com

Debt

Debt-to-Equity Ratio: -0.99
Current Ratio: 3.64
Quick Ratio: 3.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IBRX Technical Analysis vs Fundamental Analysis

Buy
72
ImmunityBio (IBRX) is a Buy

Is ImmunityBio a Buy or a Sell?

  • ImmunityBio stock is rated a Buy
    The current ImmunityBio [IBRX] share price is $7.65. The Score for IBRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.